Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues
about
Precore and core promoter mutants are associated with higher HBeAg seroconversion but low disease remission rates in HBV patients treated with nucleos(t)ide analogues
description
im Dezember 2012 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 05 December 2012
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2012
@uk
name
Precore and core promoter muta ...... patients treated with nucleos
@nl
Precore and core promoter muta ...... d with nucleos(t)ide analogues
@en
type
label
Precore and core promoter muta ...... patients treated with nucleos
@nl
Precore and core promoter muta ...... d with nucleos(t)ide analogues
@en
prefLabel
Precore and core promoter muta ...... patients treated with nucleos
@nl
Precore and core promoter muta ...... d with nucleos(t)ide analogues
@en
P2093
P2860
P356
P1476
Precore and core promoter muta ...... d with nucleos(t)ide analogues
@en
P2093
A J van Vuuren
H L A Janssen
J G P Reijnders
M J Sonneveld
R Zoutendijk
P2860
P304
P356
10.1111/JVH.12033
P577
2012-12-05T00:00:00Z